Downloads: 1
Diff of
/clusters/3009knumclusters/clust_284.txt
[000000]
..
[c09aa8]
Switch to side-by-side view
--- a +++ b/clusters/3009knumclusters/clust_284.txt @@ -0,0 +1,393 @@ +Leukocytes >= 2,500/mcL +Leukocytes >= 1,500/mcL +Leukocytes >= 2,500/mcL, within 2 weeks of randomization +Leukocytes >= 3,000/mcL +Within 14 days of treatment initiation: Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/ mm^3 +Leukocytes >= 3000/mm^3 must be obtained =< 7 days prior to protocol registration +Leukocytes >= 3,000/mm^3 +Within less than or equal to 14 days prior to registration: Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL within 4 weeks before randomization +Leukocytes >= 3,000/mcL +leukocytes ?3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes ? 3,000/mcL within 14 days of registration +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes ? 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL (>= 3,000/mm^3) +Leukocytes >= 2,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes > 3,000/mcL +Leukocytes >= 3.0 x 10^9/L +Leukocytes >= 3,000/mcL +PIK3CA WILD TYPE COHORT (closed 03/17/2016): Leukocytes >= 3,000/mcL +ENDOCRINE RESISTANT AND ADJUVANT COHORT: Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes > 3,000/mcL +Leukocytes ? 3,000/mcL +Obtained within 21 days prior to study registration: leukocytes >= 3,000/mcL +Leukocytes >= 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 1,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcl +Leukocytes >= 3,000/uL +Leukocytes >= 2,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Within 2 weeks prior to initiation of study treatment: Leukocytes >= 3,000/mcL +COHORT I: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3 x 10^9/L +Leukocytes ? 2,000/mcL +Leukocytes >= 3,000/mcL. +Leukocytes >= 3,000/mcL, =< 5 days prior to cycle 1 (C1) day 1 (D1) +Leukocytes >= 3,000/mcL. +Leukocytes >= 3,000/mcL +Leukocytes > 3,000/mcL +Leukocytes >= 3,000/mcL. +Leukocytes <3.0 x 109/L +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mm^3 +Leukocytes ? 3,000/uL +Leukocytes >= 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL. +Leukocytes >= 3,000/mcL within 14 days of treatment initiation +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Obtained within 21 days of registration: leukocytes > 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL 14 days or fewer from registration +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL (without growth factor) +Leukocytes >= 3,000/mcL +Less than 5% malignant cells in the peripheral blood leukocytes +Leukocytes >= 1500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3 x 10^9/L +Leukocytes >= 1500/mcL, within 14 days prior to treatment +Leukocytes >= 3000 mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mL +Leukocytes >= 2,000/mcL +Leukocytes > 3,000/uL +Leukocytes >= 3,000/mcL +PHASE II: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Within 14 days prior to registration: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL, obtained within 14 days of first dose of drug +Leukocytes > 3,000/uL +Leukocytes >= 3,000/uL +PHASE I: Leukocytes >= 3,000/mcL +PHASE II SCLC: Leukocytes >= 3,000/mcL +UROTHELIAL CARCINOMA EXPANSION COHORT: Leukocytes >= 3,000/mcL +mCRPC EXPANSION COHORT: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000 cells/mm^3 +Leukocytes >= 3,000/mcL +Less than 5% malignant cells in the peripheral blood leukocytes +Leukocytes: >= 3,000/mcl (lymphocyte [lymph] %: >= 10%) +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL obtained within 14 days of first treatment +Leukocytes >= 3,000/mcL +Leukocytes >= 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes < 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 2500/mL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/ul +Leukocytes > 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes > 1,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/µL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/uL (within 2 weeks prior to radiotherapy) +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mL +Within 4 weeks of preregistration: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >3,000/mcL +Leukocytes ? 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 1,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000 per mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mm^3, obtained =< 7 days prior to registration +Leukocytes >= 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes > 1,500/mcL +Leukocytes >= 3,000/mcL +DOSE ESCALATION COHORT: Leukocytes ? 3,000/mcL +DOSE EXPANSION COHORT: Leukocytes ? 3,000/mcL +Leukocytes >= 3,000/mcL +Measured within 28 days prior to administration of study treatment: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Secondary Registration: leukocytes >= 3,000/uL +Leukocytes >= 3,500/mcL +Leukocytes > 3,000/uL +Within 14 days of registration: Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Less than 5% plasma cells in the peripheral blood leukocytes +Leukocytes >= 3,000/mcL +PHASE II: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL; these results must be obtained within 28 days prior to registration +Leukocytes no lower limit +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 4,000/ul +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000 per mm^3 +Obtained within 30 days of registration: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL, within 14 days of study registration +Leukocytes >= 2,000/mcL +Leukocytes >= 2,000/uL +Leukocytes >= 3,000/uL +Leukocytes >= 3.0 x 10^9/L +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes > 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/?L +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL (labs should be performed within 14 days of treatment initiation) +Leukocytes >= 3000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes greater than 3,000/mcL +Leukocytes >= 3,000/mL +Leukocytes >= 3,000/microL +Leukocytes >= 3,000/mcL +PHASE I: Leukocytes >= 3,000/mcL +PHASE II: Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 2,000/mcL +Leukocytes > 3,000/uL +PART B: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes > 3,000/mcL +REGISTRATION INCLUSION CRITERIA: Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/uL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes ? 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes ? 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 2,500/mcL +Leukocytes >= 2,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >3,000/mm3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes: >= 3,000/mm^3 +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mm^3 +Leukocytes > 1,500/mcL +Leukocytes > 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes: >= 3,000/ul +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,00/mcL +Performed within 10 days of treatment initiation: Leukocytes >= 2,000/mcL +Leukocytes > 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/microliter (mcL) +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,500/mcL +Leukocytes >= 2,500/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3 K/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 2,000/mcL +Leukocytes >= 3000/uL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mm^3 +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes > 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/mcL +Leukocytes: >= 3,000/mm^3 +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/microliter +Leukocytes >= 2,500/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 2,500/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/uL +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/microliter +Leukocytes > 3,000/mcL +Leukocytes >= 3,000/microliter +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL (within 14 days of study registration) +Leukocytes > 3,000/uL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mL +Leukocytes >= 3,000 /uL +Leukocytes ? 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes >= 3,000/mcL +Leukocytes > 3,000/mcL +Leukocytes > 3,000/mcL +Leukocytes > 3,000/mcL +Leukocytes >= 3,000/mcL